Corix Bioscience, Inc.
CXBS
$0.00
$0.000.00%
OTC PK
| 09/30/2017 | 06/30/2017 | 09/30/2016 | |||
|---|---|---|---|---|---|
| Net Income | -165.79% | 0.00% | -12.90% | ||
| Total Depreciation and Amortization | -- | -- | -- | ||
| Total Amortization of Deferred Charges | 2,389.25% | 0.00% | -- | ||
| Total Other Non-Cash Items | 1,015.95% | 0.00% | 15.78% | ||
| Change in Net Operating Assets | -546.45% | 0.00% | -113.97% | ||
| Cash from Operations | -224.14% | 0.00% | -19.73% | ||
| Capital Expenditure | -- | -- | -- | ||
| Sale of Property, Plant, and Equipment | -- | -- | -- | ||
| Cash Acquisitions | -100.00% | 0.00% | -- | ||
| Divestitures | -- | -- | -- | ||
| Other Investing Activities | 622.40% | 0.00% | -109.51% | ||
| Cash from Investing | 526.77% | 0.00% | -114.68% | ||
| Total Debt Issued | 14.44% | 0.00% | 29.49% | ||
| Total Debt Repaid | -128.77% | 0.00% | -- | ||
| Issuance of Common Stock | -99.40% | 0.00% | -- | ||
| Repurchase of Common Stock | -- | -- | -- | ||
| Issuance of Preferred Stock | -- | -- | -- | ||
| Repurchase of Preferred Stock | -- | -- | -- | ||
| Total Dividends Paid | -- | -- | -- | ||
| Other Financing Activities | -7,641.32% | 0.00% | -112.57% | ||
| Cash from Financing | -1,283.40% | 0.00% | 139.58% | ||
| Foreign Exchange rate Adjustments | -- | -- | -- | ||
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | ||
| Net Change in Cash | 64.69% | 0.00% | 185.98% | ||